Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Up regulation and nuclear translocation of Y-box binding protein 1 (YB-1) is linked to poor prognosis in ERG-negative prostate cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-11
DOI
10.1038/s41598-017-02279-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens
- (2016) Guido Sauter et al. EUROPEAN UROLOGY
- The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
- (2015) Christoph Burdelski et al. BMC CANCER
- Expression of DNA ligase IV is linked to poor prognosis and characterizes a subset of prostate cancers harboring TMPRSS2:ERG fusion and PTEN deletion
- (2015) KATHARINA GRUPP et al. ONCOLOGY REPORTS
- YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence
- (2015) Christine Moore Sheridan et al. Oncotarget
- The Expression Level and Prognostic Value of Y-Box Binding Protein-1 in Rectal Cancer
- (2015) Yu Zhang et al. PLoS One
- Identification of proteomic biomarkers predicting prostate cancer aggressiveness and lethality despite biopsy-sampling error
- (2014) M Shipitsin et al. BRITISH JOURNAL OF CANCER
- Nuclear Y-box-binding protein-1 is a poor prognostic marker and related to epidermal growth factor receptor in uterine cervical cancer
- (2014) Shin Nishio et al. GYNECOLOGIC ONCOLOGY
- Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer
- (2014) TianTian Guo et al. HISTOPATHOLOGY
- The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG-negative prostate cancers lacking PTEN deletion is driven by KPNA2 expression
- (2014) Katharina Grupp et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer
- (2014) Masaki Shiota et al. PROSTATE
- Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies
- (2013) Dejan Knezevic et al. BMC GENOMICS
- Integrative Genomic Analyses Reveal an Androgen-Driven Somatic Alteration Landscape in Early-Onset Prostate Cancer
- (2013) Joachim Weischenfeldt et al. CANCER CELL
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box-Binding Protein-1 Promotes Prostate Cancer Progression
- (2013) K. Imada et al. CLINICAL CANCER RESEARCH
- Recurrent Rearrangements in Prostate Cancer: Causes and Therapeutic Potential
- (2013) Nicole M. White et al. CURRENT DRUG TARGETS
- Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
- (2013) Katharina Grupp et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers
- (2013) Antje Krohn et al. JOURNAL OF PATHOLOGY
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- YB-1 disrupts mismatch repair complex formation, interferes with MutSα recruitment on mismatch and inhibits mismatch repair through interacting with PCNA
- (2013) Y-W Chang et al. ONCOGENE
- Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer
- (2013) Yoo Hyun Song et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- YB-1 protein: functions and regulation
- (2013) Dmitry N. Lyabin et al. Wiley Interdisciplinary Reviews-RNA
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Y-box-binding protein 1 (YB-1) and its functions
- (2012) I. A. Eliseeva et al. BIOCHEMISTRY-MOSCOW
- Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
- (2012) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Prostate Cancer — Uncertainty and a Way Forward
- (2012) Ian M. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radical Prostatectomy versus Observation for Localized Prostate Cancer
- (2012) Timothy J. Wilt et al. NEW ENGLAND JOURNAL OF MEDICINE
- TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
- (2011) Jan C Brase et al. BMC CANCER
- Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients
- (2011) A Kolk et al. BRITISH JOURNAL OF CANCER
- Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
- (2011) J. Chad Brenner et al. CANCER CELL
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression
- (2011) M. Shiota et al. ENDOCRINE-RELATED CANCER
- YBX1 expression and function in early hematopoiesis and leukemic cells
- (2011) Jasjeet Bhullar et al. IMMUNOGENETICS
- Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
- (2011) Jack Cuzick et al. LANCET ONCOLOGY
- Prognostic Association of YB-1 Expression in Breast Cancers: A Matter of Antibody
- (2011) Adele G. Woolley et al. PLoS One
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer
- (2010) Masaki Kashihara et al. Journal of Thoracic Oncology
- Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements
- (2010) Michael C Haffner et al. NATURE GENETICS
- Coordinating the Two Protomer Active Sites of Human Topoisomerase IIα: Nicks as Topoisomerase II Poisons†
- (2009) Joseph E. Deweese et al. BIOCHEMISTRY
- Programmed Cell Death Protein 4 Down-regulates Y-Box Binding Protein-1 Expression via a Direct Interaction with Twist1 to Suppress Cancer Cell Growth
- (2009) M. Shiota et al. CANCER RESEARCH
- ETS gene fusions in prostate cancer
- (2009) Jeremy P. Clark et al. Nature Reviews Urology
- Clinical significance of p53 alterations in surgically treated prostate cancers
- (2008) Thorsten Schlomm et al. MODERN PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started